Table 2.

Week 12 PsA remission outcomes with additional variable criteria. Values are n (% of subgroup, % of total).

VariableJointa and Skinb Remission, n = 43Joint Remission Onlya, n = 30Skin Remission Onlyb, n = 101Neither Skin nor Joint Remissionc, n = 94
One additional variable
  PtGA pain ≤ 10 mm26 (60.5, 9.7)18 (60.0, 6.7)36 (35.6, 13.4)22 (23.4, 8.2)
  PtGA disease activity ≤ 10 mm27 (62.8, 10.1)14 (46.7, 5.2)35 (34.7, 13.1)13 (13.8, 4.9)
  HAQ-DI ≤ 0.531 (72.1, 11.6)23 (76.7, 8.6)50 (49.5, 18.7)40 (42.6, 14.9)
  CRP ≤ 1 mg/dld39 (90.7, 14.9)26 (89.7, 9.7)92 (92.9, 35.2)73 (81.1, 28.0)
Two additional variables
  PtGA pain ≤ 10 mm + PtGA disease activity ≤ 10 mm24 (55.8, 9.0)14 (46.7, 5.2)25 (24.8, 9.3)12 (12.8, 4.5)
  HAQ-DI ≤ 0.5 + PtGA pain ≤ 10 mm22 (51.2, 8.2)16 (53.3, 6.0)26 (25.7, 9.7)20 (21.3, 7.5)
  HAQ-DI ≤ 0.5 + PtGA disease activity ≤ 10 mm24 (55.8, 9.0)13 (43.3, 4.9)23 (22.8, 8.6)11 (11.7, 4.1)
Three additional variables
  HAQ-DI ≤ 0.5 + PtGA pain ≤ 10 mm + PtGA disease activity ≤ 10 mm21 (48.8, 7.8)13 (43.3, 4.9)18 (17.8, 6.7)10 (10.6, 3.7)
  • a TJC ≤ 1 + SJC ≤ 1.

  • b PGA = clear/almost clear.

  • c TJC > 1 + SJC > 1 + PGA > clear/almost clear.

  • d No. patients achieving joint and skin remission, joint remission only, skin remission only, and neither skin nor joint remission are 43, 29, 99, and 90, respectively. PsA: psoriatic arthritis; PtGA: patient’s global assessment; HAQ-DI: Health Assessment Questionnaire–Disability Index; CRP: C-reactive protein; TJC: tender joint count; SJC: swollen joint count; PGA: physician’s global assessment.